SCHEMBL19801452 is an investigational small molecule inhibitor targeting the PI3Kδ isoform, a kinase often implicated in the progression of hematological malignancies and various solid tumors. As a potent… Read more
SCHEMBL19801452 is an investigational small molecule inhibitor targeting the PI3Kδ isoform, a kinase often implicated in the progression of hematological malignancies and various solid tumors. As a potent PI3Kδ inhibitor, it is primarily studied for its potential to modulate aberrant signaling pathways in cancer research. This category includes the parent drug and its stable isotope labelled analogue, SCHEMBL19801452-d4, both of which serve as essential reference standards for analytical laboratories. These high-purity compounds are utilized in impurity profiling and quantitative method validation, supporting rigorous quality control processes. Researchers employ these materials to ensure accurate measurement in complex biological matrices, facilitating detailed studies on metabolic stability and pharmacokinetics throughout the drug development pipeline.